Catalent
CTLT
#1567
Rank
A$17.33 B
Marketcap
$95.52
Share price
0.67%
Change (1 day)
59.32%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Operating Margin for Catalent (CTLT)

Operating Margin as of December 2024 (TTM): -2.05%

According to Catalent's latest financial reports and stock price the company's current Operating Margin is -2.05%. At the end of 2023 the company had an Operating Margin of -3.66%.

Operating Margin history for Catalent from 2013 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2023-3.66%-125.03%
202214.62%-29.16%
202120.64%65.4%
202012.48%15.92%
201910.76%0.65%
201810.69%-1.68%
201710.88%-13.89%
201612.63%6.31%
201511.88%-5.8%
201412.61%26.63%
20139.96%-16.36%
201211.91%13.92%
201110.45%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
9.10%-543.90%๐Ÿ‡บ๐Ÿ‡ธ USA
-10.86% 429.76%๐Ÿ‡บ๐Ÿ‡ธ USA
9.98%-586.83%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-59.02% 2,779.02%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.